Report Detail

Request for Sample of this report

Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytic Agents); Disease (Hemophilia A, Hemophilia B, Hemophilia C); Treatment Type (On-demand, Prophylaxis); Therapy (Replacement Therapy, ITI Therapy, Gene Therapy, Antibody Therapy); End User (Hospitals, Clinics, Ambulatory Surgical Centres, Others), and Geography

RnM3926417
13 March, 2020
Global
225 Pages
The Insight Partners
Pharma & Healthcare

The global hemophilia treatment is expected to reach US$ 44,089.71 Mn in 2027 from US$ 14,454.81 Mn in 2019. The market is estimated to grow with a CAGR of 15.9% from 2020-2027.
The growth of the hemophilia treatment is primarily attributed to the factors such as increasing prevalence of hemophilia and rise in favorable government initiatives leading to launch of new products in the market. However, high cost related with hemophilia treatment is likely to pose a negative impact on the market growth. On the other hand, growth opportunities in emerging regions are likely to have a positive impact on the growth of the global hemophilia treatment during the forecast period.
Hemophilia is a hereditary bleeding disorder that stops the blood from clotting normally. The primary symptom is uncontrolled, often spontaneous bleeding in different areas of the body. According to data from the National Hemophilia Foundation in 2020, Hemophilia A happens in 1 in 5,000 live male births. Hemophilia A is about four times as common as hemophilia B. The number of people with hemophilia in the United States is anticipated to be around 20,000 individuals. Moreover, the incidence of hemophilia is not known across the globe but projected at above 400,000 people. Almost 75% of people with hemophilia worldwide are either undiagnosed or receive disparate treatment.
In Italy, according to the data of the National Center for Biotechnology Information (NCBI) in 2017, the number of registered people with bleeding disorders increased from about 7000 in 2000 to around 8500 in 2011 and more than 11,000 in 2015. The trend is due to an upsurge in the number of patients who are recorded, mainly in those with vWD type 1, mild hemophilia, or other factor deficiencies. Thus, increasing prevalence of hemophilia, high cases of under-diagnosed hemophilia cases, and improving healthcare infrastructure will eventually grow the market for hemophilia treatment in the forecast period.
Global hemophilia treatment, based on the product, is segmented into plasma derived coagulation factor concentrates plasma derived coagulation factor concentrates, desmopressin, antifibrinolytic agents. In 2019, the recombinant coagulation factor concentrates held the largest share of the market, by product. Also, recombinant coagulation factor concentrates segment is expected to grow at the fastest rate during the coming years owing to increasing adoption of integrated systems across the globe.
Some of the major primary and secondary sources for Hemostats included in the report are Centers for Disease Control and Prevention (CDC), USFDA, Central Intelligence Agency (CIA), National Clinical Database, and others.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Hemophilia Treatment Market – By Product
- 1.3.2 Global Hemophilia Treatment Market – By Disease
- 1.3.3 Global Hemophilia Treatment Market – By Treatment Type
- 1.3.4 Global Hemophilia Treatment Market – By Therapy
- 1.3.5 Global Hemophilia Treatment Market – By End User
- 1.3.6 Global Hemophilia Treatment Market – By Geography

2. Global Hemophilia Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Hemophilia Treatment– Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America – PEST Analysis
- 4.2.2 Europe: PEST Analysis
- 4.2.3 APAC: PEST Analysis
- 4.2.4 MEA: PEST Analysis
- 4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinion

5. Hemophilia Treatment Market – Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Hemophilia
- 5.1.2 Rise in Favorable Government Initiatives
5.2 Market Restraints
- 5.2.1 High Cost Related with Hemophilia Treatment
5.3 Market Opportunities
- 5.3.1 Growth in the Global Healthcare Market
5.4 Future Trends
- 5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis

6. Hemophilia Treatment Market – Global Analysis

6.1 Global Hemophilia Treatment Market Revenue Forecast And Analysis
6.2 Global Hemophilia Treatment Market, By Geography - Forecast And Analysis
6.3 Positioning of Key Players
- 6.3.1 Bayer AG
- 6.3.2 Pfizer Inc.

7. Global Hemophilia Treatment Market Analysis– by Product

7.1 Overview
7.2 Hemophilia Treatment Market Revenue Share, by Product (2019 and 2027)
7.3 Plasma-Derived Coagulation Factor Concentrates
- 7.3.1 Overview
- 7.3.2 Plasma-Derived Coagulation Factor Concentrates: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 7.3.3 Factor VIII
  - 7.3.3.1 Overview
  - 7.3.3.2 Factor VIII: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 7.3.4 Factor IX
  - 7.3.4.1 Overview
  - 7.3.4.2 Factor IX: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 7.3.5 Factor XII
  - 7.3.5.1 Overview
  - 7.3.5.2 Factor XII: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 7.3.6 Activated Prothrombin Complex Concentrates
  - 7.3.6.1 Overview
  - 7.3.6.2 Activated Prothrombin Complex Concentrates: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 7.3.7 Von Willebrand Factor
  - 7.3.7.1 Overview
  - 7.3.7.2 Von Willebrand Factor: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Recombinant Coagulation Factor Concentrates
- 7.4.1 Overview
- 7.4.2 Recombinant Coagulation Factor Concentrates: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 7.4.3 Factor VIII
  - 7.4.3.1 Overview
  - 7.4.3.2 Factor VIII: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
- 7.4.4 Factor IX
  - 7.4.4.1 Overview
  - 7.4.4.2 Factor IX: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Desmopressin
- 7.5.1 Overview
- 7.5.2 Desmopressin: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Antifibrinolytic Agents
- 7.6.1 Overview
- 7.6.2 Antifibrinolytic Agents: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)

8. Hemophilia Treatment Market Analysis– by Disease

8.1 Overview
8.2 Hemophilia Treatment Market, by Disease 2019 and 2027 (%)
8.3 Hemophilia A
- 8.3.1 Overview
- 8.3.2 Hemophilia A: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Hemophilia B
- 8.4.1 Overview
- 8.4.2 Hemophilia B: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Hemophilia C
- 8.5.1 Overview
- 8.5.2 Hemophilia C: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)

9. Hemophilia Treatment Market Analysis – by Treatment Type

9.1 Overview
9.2 Hemophilia Treatment Market Revenue Share, by Treatment Type (2019 and 2027)
9.3 Prophylaxis
- 9.3.1 Overview
- 9.3.2 Prophylaxis: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
9.4 On-demand
- 9.4.1 Overview
- 9.4.2 On-demand: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)

10. Hemophilia Treatment Market Analysis– by Therapy

10.1 Overview
10.2 Hemophilia Treatment Market, by Therapy 2019 and 2027 (%)
10.3 Replacement Therapy
- 10.3.1 Overview
- 10.3.2 Replacement Therapy: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
10.4 ITI Therapy
- 10.4.1 Overview
- 10.4.2 ITI Therapy: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
10.5 Gene Therapy
- 10.5.1 Overview
- 10.5.2 Gene Therapy: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)

11. Hemophilia Treatment Market Analysis– by End User

11.1 Overview
11.2 Hemophilia Treatment Market, by End User 2019 and 2027 (%)
11.3 Hospitals & Clinics
- 11.3.1 Overview
- 11.3.2 Hospitals & Clinics: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
11.4 Hemophilia Treatment Centers
- 11.4.1 Overview
- 11.4.2 Hemophilia Treatment Centers: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)
11.5 Ambulatory Surgical Centers
- 11.5.1 Overview
- 11.5.2 Ambulatory Surgical Centers: Hemophilia Treatment Market – Revenue and Forecast to 2027 (US$ Million)

12. Hemophilia Treatment Market – Geographic Analysis

12.1 North America: Hemophilia Treatment Market
- 12.1.1 North America Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
- 12.1.2 North America Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.1.2.1 North America Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.1.2.2 North America Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
- 12.1.3 North America Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
- 12.1.4 North America Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
- 12.1.5 North America Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
- 12.1.6 North America Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.1.7 North America Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
- 12.1.8 US Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.1.8.1 US Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.1.8.2 US Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.1.8.2.1 US Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.1.8.2.2 US Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.1.8.3 US Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.1.8.4 US Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.1.8.5 US Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.1.8.6 US Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.1.9 Canada Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.1.9.1 Canada Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.1.9.2 Canada Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.1.9.2.1 Canada Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.1.9.2.2 Canada Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.1.9.3 Canada Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.1.9.4 Canada Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.1.9.5 Canada Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.1.9.6 Canada Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.1.10 Mexico Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.1.10.1 Mexico Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.1.10.2 Mexico Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.1.10.2.1 Mexico Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.1.10.2.2 Mexico Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.1.10.3 Mexico Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.1.10.4 Mexico Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.1.10.5 Mexico Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.1.10.6 Mexico Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
12.2 Europe: Hemophilia Treatment Market
- 12.2.1 Overview
- 12.2.2 Europe Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
- 12.2.3 Europe Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.2.3.1 Europe Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.3.2 Europe Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
- 12.2.4 Europe Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
- 12.2.5 Europe Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
- 12.2.6 Europe Hemophilia Treatment Market, by Therapy– Revenue and Forecast to 2027 (USD Million)
- 12.2.7 Europe Hemophilia Treatment Market, by End User– Revenue and Forecast to 2027 (USD Million)
- 12.2.8 Europe Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
- 12.2.9 Germany Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.2.9.1 Germany Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  - 12.2.9.2 Germany Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.2.9.2.1 Germany Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.9.2.2 Germany Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.9.3 Germany Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.2.9.4 Germany Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.9.5 Germany Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.2.9.6 Germany Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.2.10 UK Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.2.10.1 UK Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  - 12.2.10.2 UK Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.2.10.2.1 UK Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.10.2.2 UK Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.10.3 UK Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.2.10.4 UK Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.10.5 UK Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.2.10.6 UK Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.2.11 France Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.2.11.1 France Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  - 12.2.11.2 France Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.2.11.2.1 France Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.11.2.2 France Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.11.3 France Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.2.11.4 France Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.11.5 France Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.2.11.6 France Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.2.12 Spain Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.2.12.1 Spain Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  - 12.2.12.2 Spain Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.2.12.2.1 Spain Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.12.2.2 Spain Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.12.3 Spain Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.2.12.4 Spain Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.12.5 Spain Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.2.12.6 Spain Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.2.13 Italy Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.2.13.1 Italy Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  - 12.2.13.2 Italy Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.2.13.2.1 Italy Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.13.2.2 Italy Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.13.3 Italy Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.2.13.4 Italy Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.2.13.5 Italy Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.2.13.6 Italy Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
12.3 APAC: Hemophilia Treatment Market
- 12.3.1 Asia Pacific Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
- 12.3.2 Asia Pacific Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.3.2.1 Asia Pacific Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.2.2 Asia Pacific Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
- 12.3.3 Asia Pacific Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
- 12.3.4 Asia Pacific Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
- 12.3.5 Asia Pacific Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
- 12.3.6 Asia Pacific Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.3.7 Asia Pacific Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
- 12.3.8 Japan
  - 12.3.8.1 Japan Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.3.8.2 Japan Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.3.8.2.1 Japan Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.8.2.2 Japan Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.8.3 Japan Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.3.8.4 Japan Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.8.5 Japan Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.3.8.6 Japan Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.3.9 China
  - 12.3.9.1 China Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.3.9.2 China Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.3.9.2.1 China Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.9.2.2 China Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.9.3 China Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.3.9.4 China Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.9.5 China Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.3.9.6 China Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.3.10 India
  - 12.3.10.1 India Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.3.10.2 India Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.3.10.2.1 India Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.10.2.2 India Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.10.3 India Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.3.10.4 India Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.10.5 India Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.3.10.6 India Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.3.11 South Korea
  - 12.3.11.1 South Korea Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.3.11.2 South Korea Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.3.11.2.1 South Korea Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.11.2.2 South Korea Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.11.3 South Korea Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.3.11.4 South Korea Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.11.5 South Korea Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.3.11.6 South Korea Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.3.12 Australia
  - 12.3.12.1 Australia Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.3.12.2 Australia Hemophilia Treatment Market, by Disease– Revenue and Forecast to 2027 (USD Million)
  - 12.3.12.2.1 Australia Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.12.2.2 Australia Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.12.3 Australia Hemophilia Treatment Market, by Disease– Revenue and Forecast to 2027 (USD Million)
  - 12.3.12.4 Australia Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.3.12.5 Australia Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.3.12.6 Australia Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
12.4 Middle East & Africa: Hemophilia Treatment Market
- 12.4.1 Overview
- 12.4.2 Middle East & Africa Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
- 12.4.3 Middle East & Africa Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.4.3.1 Middle East & Africa Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.4.3.2 Middle East & Africa Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
- 12.4.4 Middle East & Africa Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
- 12.4.5 Middle East & Africa Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
- 12.4.6 Middle East & Africa Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
- 12.4.7 Middle East & Africa Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.4.8 Middle East & Africa Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
- 12.4.9 Saudi Arabia
  - 12.4.9.1 Saudi Arabia Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  - 12.4.9.2 Saudi Arabia Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.4.9.2.1 Saudi Arabia Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.4.9.2.2 Saudi Arabia Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.4.9.3 Saudi Arabia Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.4.9.4 Saudi Arabia Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.4.9.5 Saudi Arabia Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.4.9.6 Saudi Arabia Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.4.10 UAE
  - 12.4.10.1 UAE Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  - 12.4.10.1.1 UAE Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.4.10.1.2 UAE Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.4.10.2 UAE Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.4.10.3 UAE Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.4.10.4 UAE Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.4.10.5 UAE Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.4.11 South Africa
  - 12.4.11.1 South Africa Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
  - 12.4.11.2 South Africa Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.4.11.2.1 South Africa Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.4.11.2.2 South Africa Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.4.11.3 South Africa Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.4.11.4 South Africa Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.4.11.5 South Africa Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.4.11.6 South Africa Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
12.5 South And Central America: Hemophilia Treatment Market
- 12.5.1 South and Central America Hemophilia Treatment Market, Revenue and Forecast to 2027 (US$ Mn)
- 12.5.2 South and Central America Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.5.2.1 South and Central America Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.5.2.2 South and Central America Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
- 12.5.3 South and Central America Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
- 12.5.4 South and Central America Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
- 12.5.5 South and Central America Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
- 12.5.6 South and Central America Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.5.7 South and Central America Hemophilia Treatment Market, by Country, 2019 & 2027 (%)
- 12.5.8 Brazil
  - 12.5.8.1 Brazil Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.5.8.2 Brazil Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.5.8.2.1 Brazil Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.5.8.2.2 Brazil Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.5.8.3 Brazil Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.5.8.4 Brazil Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.5.8.5 Brazil Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.5.8.6 Brazil Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
- 12.5.9 Argentina
  - 12.5.9.1 Argentina Hemophilia Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
  - 12.5.9.2 Argentina Hemophilia Treatment Market, by Product – Revenue and Forecast to 2027 (USD Million)
  - 12.5.9.2.1 Argentina Plasma Derived Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.5.9.2.2 Argentina Recombinant Coagulation Factor Concentrates Market, by Type – Revenue and Forecast to 2027 (USD Million)
  - 12.5.9.3 Argentina Hemophilia Treatment Market, by Disease – Revenue and Forecast to 2027 (USD Million)
  - 12.5.9.4 Argentina Hemophilia Treatment Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
  - 12.5.9.5 Argentina Hemophilia Treatment Market, by Therapy – Revenue and Forecast to 2027 (USD Million)
  - 12.5.9.6 Argentina Hemophilia Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)
13. Global Hemophilia Treatment Market – Industry Landscape
- 13.1 Overview
- 13.2 Growth Strategies Done By the Companies in the Market, (%)
- 13.3 Organic Developments Done By The Companies in The Market
- 13.4 Inorganic Developments Done by The Companies In The Market
14. COMPANY PROFILES
- 14.1 Bayer AG
  - 14.1.1 Key Facts
  - 14.1.2 Business Description
  - 14.1.3 Products and Services
  - 14.1.4 Financial Overview
  - 14.1.5 SWOT Analysis
  - 14.1.6 Key Developments
- 14.2 Sanofi
  - 14.2.1 Key Facts
  - 14.2.2 Business Description
  - 14.2.3 Products and Services
  - 14.2.4 Financial Overview
  - 14.2.5 SWOT Analysis
  - 14.2.6 Key Developments
- 14.3 F. Hoffmann-La Roche Ltd
  - 14.3.1 Key Facts
  - 14.3.2 Business Description
  - 14.3.3 Products and Services
  - 14.3.4 Financial Overview
  - 14.3.5 SWOT Analysis
  - 14.3.6 Key Developments
- 14.4 Kedrion S.p.A
  - 14.4.1 Key Facts
  - 14.4.2 Business Description
  - 14.4.3 Products and Services
  - 14.4.4 Financial Overview
  - 14.4.5 SWOT Analysis
  - 14.4.6 Key Developments
- 14.5 CSL Limited
  - 14.5.1 Key Facts
  - 14.5.2 Business Description
  - 14.5.3 Products and Services
  - 14.5.4 Financial Overview
  - 14.5.5 SWOT Analysis
  - 14.5.6 Key Developments
- 14.6 Biotest AG.
  - 14.6.1 Key Facts
  - 14.6.2 Business Description
  - 14.6.3 Products and Services
  - 14.6.4 Financial Overview
  - 14.6.5 SWOT Analysis
  - 14.6.6 Key Developments
- 14.7 Pfizer Inc.
  - 14.7.1 Key Facts
  - 14.7.2 Business Description
  - 14.7.3 Products and Services
  - 14.7.4 Financial Overview
  - 14.7.5 SWOT Analysis
  - 14.7.6 Key Developments
- 14.8 Novo Nordisk A/S
  - 14.8.1 Key Facts
  - 14.8.2 Business Description
  - 14.8.3 Products and Services
  - 14.8.4 Financial Overview
  - 14.8.5 SWOT Analysis
  - 14.8.6 Key Developments
- 14.9 Octapharma AG
  - 14.9.1 Key Facts
  - 14.9.2 Business Description
  - 14.9.3 Products and Services
  - 14.9.4 Financial Overview
  - 14.9.5 SWOT Analysis
  - 14.9.6 Key Developments
- 14.10 Baxter International Inc.
  - 14.10.1 Key Facts
  - 14.10.2 Business Description
  - 14.10.3 Products and Services
  - 14.10.4 Financial Overview
  - 14.10.5 SWOT Analysis
  - 14.10.6 Key Developments
15. Appendix
- 15.1 About The Insight Partners

Security Advisory Services Market Report

Quartz Market Report

Summary:
Get latest Market Research Reports on Hemophilia Treatment . Industry analysis & Market Report on Hemophilia Treatment is a syndicated market report, published as Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytic Agents); Disease (Hemophilia A, Hemophilia B, Hemophilia C); Treatment Type (On-demand, Prophylaxis); Therapy (Replacement Therapy, ITI Therapy, Gene Therapy, Antibody Therapy); End User (Hospitals, Clinics, Ambulatory Surgical Centres, Others), and Geography . It is complete Research Study and Industry Analysis of Hemophilia Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on 13 March, 2020

1-User License	$4,550.00
Site License	$6,550.00
Enterprise License	$8,550.00

1-User License	3,517.15
Site License	5,063.15
Enterprise License	6,609.15

1-User License	4,236.05
Site License	6,098.05
Enterprise License	7,960.05

1-User License	694,739.50
Site License	1,000,119.50
Enterprise License	1,305,499.50

1-User License	384,020.00
Site License	552,820.00
Enterprise License	721,620.00

Report Detail

Request for Sample of this report

Request for Sample of this report

Table Of Content

TABLE OF CONTENTS

1. Introduction

2. Global Hemophilia Treatment Market – Key Takeaways

3. Research Methodology

4. Hemophilia Treatment– Market Landscape

5. Hemophilia Treatment Market – Key Market Dynamics

6. Hemophilia Treatment Market – Global Analysis

7. Global Hemophilia Treatment Market Analysis– by Product

8. Hemophilia Treatment Market Analysis– by Disease

9. Hemophilia Treatment Market Analysis – by Treatment Type

10. Hemophilia Treatment Market Analysis– by Therapy

11. Hemophilia Treatment Market Analysis– by End User

12. Hemophilia Treatment Market – Geographic Analysis

13. Global Hemophilia Treatment Market – Industry Landscape

14. COMPANY PROFILES

15. Appendix

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

Related Reports

Reason to Buy

Trusted By Leaders

Shop With Confidence

Customer Centric

Personalized Solutions

Secure Checkout

Request for Sample of this report

Reports and Markets

Contact Us

Support

Newsletter